Japanese Poster Session

[Pj-019] Neuroimmunology (MS and clinical research))

Wed. May 22, 2019 5:20 PM - 6:35 PM Poster Exhibition (Osaka International Convention Center 3F Event Hall)

Chair:Yuko Shimizu(Department of Neurology, Tokyo Women's Medical Univeristy)

+Add all to schedule

[Pj-019-1] Melanoma cell adhesion molecule-expressing lymphocyte in CNS demyelinating diseases

Ryotaro Ikeguchi¹, Yuko Shimizu¹, Wakiro Sato², Takashi Yamamura², Kazuo Kitagawa¹ (1.Department of Neurology, Tokyo Women's Medical University, 2.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

[Pj-019-2] Peroxiredoxins' role in the pathogenesis of CNS inflammatory demyelinating disorders

Akiyuki Uzawa, Masahiro Mori, Ryohei Ohtani, Tomohiko Uchida, Hiroki Masuda, Satoshi Kuwabara (Department of Neurology, Graduate School of Medicine, Chiba University)

[Pj-019-3] Immunopathogenesis of the Central Nervous System in Multiple Sclerosis and Neuromyelitis Optica

Makoto Matsui¹, Nobuaki Uchida¹, Michiyo Fujita-nakata¹, Megumi Nakanishi¹, Mitsuru Sanada¹, Shigemi Nagayama¹, Ryuji Kaji² (1.Department of Neurology, Kanazawa Medical University, 2.National Hospital Organization Utano Hospital)

[Pj-019-4] PD-1+CD8+ T cells correlates with good responses for acute treatments of Multiple Sclerosis

Shusuke Koto¹, Norio Chihara¹, Ritsu Akatani¹, Kenji Sekiguchi¹, Tatsushi Toda² (1.Division of Neurology, Kobe University Graduate School of Medicine, 2.Department of Neurology, Graduate School of Medicine, The University of Tokyo)

[Pj-019-5] Influence of dimethyl fumarate on T/B lymphocyte subset of multiple sclerosis

Satoru Tanaka, Baku Hashimoto, Shoko Izaki, Satoru Oji, Tomohisa Denbo, Hikoaki Fukaura, Kyoichi Nomura (Saitama Medical University, Saitama Medical Center)

[Pj-019-6] Influence for Lymphocyte count on Dimethyl Fumarate treatment in Japanese patients with MS

Ichiro Nakashima¹, Kazumasa Yokoyama², Takahiko Saida³, Ryusuke Sato⁴, Haruki Makioka⁴, Michihiro Kanda⁴, Yasuhiro Onizuka⁴, Nami Sugiyama⁴, Naoto Matsuda⁴, Shinichi Torii⁴ (1.Department of Neurology, Tohoku Medical and Pharmaceutical University, 2.Department of Neurology, Juntendo University School of Medicine, 3.Kansai Multiple Sclerosis Center, Kyoto Min-iren Central Hospital, 4.Biogen Japan Ltd)